Ajooni Biotech Profile
Key Indicators
- Authorised Capital ₹ 40.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 34.45 Cr
as on 15-11-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.42 Cr
as on 15-11-2024
- Satisfied Charges ₹ 8.86 Cr
as on 15-11-2024
- Revenue 0.95%
(FY 2023)
- Profit 7.23%
(FY 2023)
- Ebitda -10.02%
(FY 2023)
- Net Worth 154.35%
(FY 2023)
- Total Assets 102.40%
(FY 2023)
About Ajooni Biotech
It is listed on the National Stock Exchange(NSE) under the ticker symbol AJOONI.
The Corporate was formerly known as Ajooni Biotech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 34.45 Cr.
The company currently has active open charges totaling ₹14.42 Cr. The company has closed loans amounting to ₹8.86 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ajooni Biotech Limited India are Jasjot Singh as CFO and Swati Vijan as Company Secretary. Jasjot Singh, Gursimran Singh, Partek Singh, and Three other members serve as directors at the Company.
- CIN/LLPIN
L85190PB2010PLC040162
- Company No.
040162
- Stock Symbol
NSE : AJOONI
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2010
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ajooni Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jasjot Singh  | Managing Director | 30-Dec-2013 | Current |
| Swati Vijan | Company Secretary | 12-Feb-2020 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gursimran Singh | Whole-Time Director | 26-Dec-2014 | Current |
| Partek Singh | Director | 30-Jun-2017 | Current |
| Imteshwar Bhatia | Director | 02-Aug-2017 | Current |
| Simmi Chhabra | Director | 02-Aug-2017 | Current |
| Ramandeep Singh | Director | 02-Aug-2017 | Current |
Financial Performance and Corporate Structure Insights of Ajooni Biotech.
Ajooni Biotech Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.95% increase. The company also saw a slight improvement in profitability, with a 7.23% increase in profit. The company's net worth Soared by an impressive increase of 154.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ajooni Biotech?
In 2023, Ajooni Biotech had a promoter holding of 36.39% and a public holding of 63.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Healthy Biosciences LimitedActive 16 years 5 months
Jasjot Singh, Gursimran Singh and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 04 Sep 2024 | ₹2.40 M | Open |
Canara Bank Creation Date: 20 Mar 2024 | ₹3.80 M | Open |
Hdfc Bank Limited Creation Date: 18 Dec 2021 | ₹1.06 M | Open |
How Many Employees Work at Ajooni Biotech?
Ajooni Biotech has a workforce of 15 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajooni Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajooni Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
